NCT02707003

Brief Summary

Multi-center observational trial with study device blinded in order to assess in parallel standard monitoring and intervention practices related to management of respiratory compromise in the post-anaesthesia care unit (PACU)

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 7, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 11, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2018

Completed
Last Updated

July 23, 2020

Status Verified

July 1, 2020

Enrollment Period

1.4 years

First QC Date

March 7, 2016

Last Update Submit

July 21, 2020

Conditions

Keywords

Post-operative respiratory distress

Outcome Measures

Primary Outcomes (1)

  • Frequency of Respiratory Adverse Events in the PACU identified by capnography

    Identification by blinded capnography to understand the ventilation challenges of patient in the PACU during standard of care that does not include capnography. First tier is RN (Registered Nurse) level of notification for early intervention and second tier is level at which covering MD (Medical Doctor) might request notification: 1. High Respiration Rate \>25 bpm for \> 15 seconds (tier one) and \>30 bpm for more than 30 seconds (tier two) 2. Low Respiration Rate \< 8 bpm for more than 15 seconds and \< 6 bpm for more than 30 seconds 3. High end tidal CO2 (EtCO2) \> 55 mmHg for \> 15 seconds and \> 60 mmHg for more than 30 seconds 4. Low EtCO2 \< 25 mmHg for \> 15 seconds and \< 25 mmHg for more than 30 seconds 5. High Heart Rate \> 120/min for 15 seconds and \>120/min for 30 seconds 6. Low Heart Rate \< 40/min for 15 seconds and \< 40/min for 30 seconds 7. SpO2 (oxygen saturation by pulse oximetry) /Hypoxemia \< 90% for more than 15 seconds and\< 90% for more than 30 seconds

    Up to 2 hours in the PACU

Secondary Outcomes (2)

  • Frequency of Critical Adverse Events (CRAE)

    PACU and 24 hours post PACU

  • Ventilation insufficiency on transfer from the PACU

    At PACU discharge

Study Arms (2)

AZ PACU

Observation of standard of care with capnography blinded

TWH PACU

Observation of standard of care with capnography blinded

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults booked for a surgical procedure that meet the I/E criteria and willing to provide consent for observation in the PACU and chart review 24 hours post PACU discharge.

You may qualify if:

  • Adult ≥ 18 years of age
  • ASA Score II - IV (American Society of Anaesthesiologists Score)
  • Patients booked for a surgical procedure requiring general anesthesia care
  • Expected duration of general anesthesia to be \> 1.5 hours
  • Expected to receive intraoperative opioids
  • Expected to be transferred to the PACU from the operating room
  • Patients with an expected duration in the PACU ≥ 45 minutes
  • Expected to be transferred from the PACU to an in-patient setting

You may not qualify if:

  • Patients expected to be discharged from the hospital when discharged from the PACU
  • Subjects who will have oral/nasal surgery that may prevent wearing an oral/nasal capnography sampling filterline.
  • Subjects with a history of severe contact allergies that may cause a reaction to standard adhesive materials found in pulse oximetry sensors.
  • Patients with skin lesions or physical deformities that would prevent the application of finger sensors for optimal performance.
  • A female known to be pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Banner University Medical Center

Tucson, Arizona, 85724-5114, United States

Location

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Location

Related Publications (2)

  • Kanaparthi A, Chung F, Lichtenthal PR, Sprung J, Weingarten TN. PRODIGY score predicts respiratory depression in the post-anesthesia care unit: A post-hoc analysis. Biomol Biomed. 2024 Oct 17;24(6):1662-1668. doi: 10.17305/bb.2024.10585.

  • Chung F, Wong J, Mestek ML, Niebel KH, Lichtenthal P. Characterization of respiratory compromise and the potential clinical utility of capnography in the post-anesthesia care unit: a blinded observational trial. J Clin Monit Comput. 2020 Jun;34(3):541-551. doi: 10.1007/s10877-019-00333-9. Epub 2019 Jun 7.

Related Links

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Peter R Lichtenthal, MD

    Banner University Medical Center

    PRINCIPAL INVESTIGATOR
  • Francis F Chung, MBBS FRCPC

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2016

First Posted

March 11, 2016

Study Start

February 1, 2016

Primary Completion

June 15, 2017

Study Completion

June 15, 2018

Last Updated

July 23, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations